Progress in Serodiagnosis of Mycobacterium tuberculosis Infection

F Abebe, C Holm‐Hansen, HG Wiker… - … journal of immunology, 2007 - Wiley Online Library
One‐third of the world population is estimated to have Mycobacterium tuberculosis infection.
Accurate and timely identification of infected individuals is critical for treatment and control …

Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant …

J Singh, T Garg, G Rath, AK Goyal - Drug delivery, 2016 - Taylor & Francis
From the early sixteenth and seventeenth centuries to the present day of life, tuberculosis
(TB) still is a global health threat with some new emergence of resistance. This type of …

Human isotype‐dependent inhibitory antibody responses against Mycobacterium tuberculosis

N Zimmermann, V Thormann, B Hu… - EMBO molecular …, 2016 - embopress.org
Accumulating evidence from experimental animal models suggests that antibodies play a
protective role against tuberculosis (TB). However, little is known about the antibodies …

Regulatory T cells depress immune responses to protective antigens in active tuberculosis

JM Hougardy, S Place, M Hildebrand… - American journal of …, 2007 - atsjournals.org
Rationale: Tuberculosis (TB) remains a leading cause of death, and the role of T-cell
responses to control Mycobacterium tuberculosis infections is well recognized. Patients with …

Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin

S Temmerman, K Pethe, M Parra, S Alonso… - Nature medicine, 2004 - nature.com
Although post-translational modifications of protein antigens may be important componenets
of some B cell epitopes, the determinants of T cell immunity are generally nonmodified …

Heparin-binding-hemagglutinin-induced IFN-γ release as a diagnostic tool for latent tuberculosis

JM Hougardy, K Schepers, S Place, A Drowart… - PloS one, 2007 - journals.plos.org
Background The detection of latent tuberculosis infection (LTBI) is a major component of
tuberculosis (TB) control strategies. In addition to the tuberculosis skin test (TST), novel …

T-cell immunophenotyping distinguishes active from latent tuberculosis

KM Pollock, HS Whitworth… - The Journal of …, 2013 - academic.oup.com
Background. Changes in the phenotype and function of Mycobacterium tuberculosis (M.
tuberculosis)-specific CD4+ and CD8+ T-cell subsets in response to stage of infection may …

[HTML][HTML] Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination

M Coppola, THM Ottenhoff - Seminars in immunology, 2018 - Elsevier
Every day approximately six thousand people die of Tuberculosis (TB). Its causative agent,
Mycobacterium tuberculosis (Mtb), is an ancient pathogen that through its evolution …

Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis

K Pethe, P Bifani, H Drobecq… - Proceedings of the …, 2002 - National Acad Sciences
Mycobacterium tuberculosis and Mycobacterium bovis bacillus Calmette–Guérin produce a
heparin-binding hemagglutinin adhesin (HBHA) required for extrapulmonary dissemination …

Intracellular cytokine staining and flow cytometry: considerations for application in clinical trials of novel tuberculosis vaccines

SG Smith, K Smits, SA Joosten, KE van Meijgaarden… - PloS one, 2015 - journals.plos.org
Intracellular cytokine staining combined with flow cytometry is one of a number of assays
designed to assess T-cell immune responses. It has the specific advantage of enabling the …